Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity Hospital, Bordeaux
About this trial
This prospective and observational study aims to evaluate the accumulation of advanced glycation end-products (AGEs) in adult and pediatric patients starting long-term parenteral nutrition, by non-invasive skin AGE measurements over a 12-month follow-up.
Eligibility criteria
Qualifiers
Patients (adults and children, all ages) initiating long-term parenteral nutrition
Followed at CHU de Bordeaux or Robert Debré Hospital (APHP)
Covered by French Social Security system
Written informed consent obtained from patient (if adult) or legal guardian (if minor)
Disqualifiers
Fitzpatrick skin type ≥ V (darker skin tones)
Forearm tattoos at the site of measurement
For patients included under 1 year of age: patients born prematurely (before 37 weeks of amenorrhea)
Pregnant or breastfeeding women.
Trial design
Treatments tested in this trial
- Non-invasive skin AGE measurements
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov